Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

London Health Sciences Centre

London, KanadahealthcareHonlap

Más néven: LHSU

160futó vizsgálat
59lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
NCT07858331· 4. fázis· Forrás
Még nem toboroz
Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
NCT07831122· 1. fázis· Forrás
Még nem toboroz
A Randomized Trial of Standard vs. Hypofractionated Accelerated Radiotherapy for Progression in Limited-Stage Small Cell Lung Cancer
NCT07920549· 2/3. fázis· Forrás
Még nem toboroz
The BASIC-S Feasibility Study for Vascular Risk Reduction
NCT07755631· Forrás
Toboroz
TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS
NCT07893964· 2. fázis· Forrás
Még nem toboroz
Trauma Therapy for Weight-Based Bullying in Children
NCT07685990· Forrás
Még nem toboroz
MICRO-ultrasound Guided Prostate SBRT
NCT07737457· Forrás
Még nem toboroz
Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1)
NCT07680322· 2. fázis· Forrás
Toboroz
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007· 2. fázis· Forrás
Toboroz
Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial
NCT07300566· Forrás
Még nem toboroz
Staph Nasal Decolonization to Improve Function and Feeding
NCT07524894· 2. fázis· Forrás
Toboroz
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892· 2/3. fázis· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
NCT07416604· 3. fázis· Forrás
Toboroz
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation
NCT07192016· 4. fázis· Forrás
Toboroz
Restrictive Fluid Management In Liver Transplantation (REFIL)
NCT07695363· Forrás
Toboroz
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511· 3. fázis· Forrás
Még nem toboroz
FMT in Triple Negative Breast Cancer Guided by ctDNA
NCT07292142· 1/2. fázis· Forrás
Toboroz
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703· 3. fázis· Forrás
Toboroz
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566· 3. fázis· Forrás
Még nem toboroz
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
NCT07066163· Forrás
Toboroz
Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication
NCT07272902· Forrás
Toboroz
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199· 3. fázis· Forrás
Toboroz
Oral Carnitine in Heart Failure Patients
NCT07201714· Korai 1. fázis· Forrás
Toboroz
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101· 2. fázis· Forrás
Toboroz
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
NCT07027436· 3. fázis· Forrás
Még nem toboroz
Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy
NCT07076914· 2. fázis· Forrás
Fut, nem toboroz
Study of COYA 302 for the Treatment of ALS
NCT07161999· 2/3. fázis· Forrás
Toboroz
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
NCT06745908· 3. fázis· Forrás
Toboroz
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT06942039· Korai 1. fázis· Forrás
Toboroz
DIALysis With EXpanded Solute Removal
NCT06660277· Forrás
Toboroz
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
NCT07100119· 1. fázis· Forrás
Toboroz
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519· 3. fázis· Forrás
Toboroz
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755· 2/3. fázis· Forrás
Toboroz
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497· 3. fázis· Forrás
Toboroz
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827· 3. fázis· Forrás
Toboroz
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086· 3. fázis· Forrás
Toboroz
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099· 3. fázis· Forrás
Toboroz
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
NCT06337838· 3. fázis· Forrás
Toboroz
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504· 3. fázis· Forrás
Toboroz
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
NCT06850766· Forrás
Toboroz
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285· 3. fázis· Forrás
Toboroz
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
NCT06846671· 3. fázis· Forrás
Toboroz
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
NCT06665165· 1. fázis· Forrás
Toboroz
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648· Forrás
Még nem toboroz
Genomic First Testing in Chronic Kidney Disease
NCT06794567· Forrás
Toboroz
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
NCT05986318· 2. fázis· Forrás
Még nem toboroz
Surgery and Reducing Ionizing Radiation of the Unknown Primary
NCT06578871· 2. fázis· Forrás
Fut, nem toboroz
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
NCT06593522· 2. fázis· Forrás
Toboroz
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
NCT06736574· 3. fázis· Forrás
Toboroz
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
NCT05272826· 2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Toboroz
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161· 3. fázis· Forrás
Toboroz
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779· 3. fázis· Forrás
Lezárult
Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)
NCT06203977· 2. fázis· Forrás
Lezárult
Real-World Effectiveness of Mavacamten in Canada
NCT06338202· Forrás
Lezárult
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06049017· 2. fázis· Forrás
Lezárult
The Extended CTA for the Successful Screening of Cardioaortic Thrombus in Acute Ischemic Stroke and TIA (DAYLIGHT) Trial
NCT05522244· Forrás
Lezárult
Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend
NCT05118893· Forrás
Lezárult
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· 3. fázis· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Forrás
Lezárult
TESTING -ON Post-Trial ObservatioNal Cohort Study
NCT05434325· Forrás
Lezárult
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
NCT05614063· 3. fázis· Forrás
Lezárult
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
NCT05081245· 2. fázis· Forrás
Lezárult
Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments
NCT04248920· Forrás
Leállították
THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
NCT05033314· 3. fázis· Forrás
Lezárult
Virtual Reality for Port-a-Cath Access
NCT04931745· Forrás
Lezárult
Radioligand fOr locAl raDiorecurrent proStaTe cancER
NCT05230251· 1/2. fázis· Forrás
Lezárult
Same Day Discharge for Wedge Resection
NCT05067738· Forrás
Lezárult
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
NCT04779307· 3. fázis· Forrás
Leállították
A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis
NCT04948645· 1. fázis· Forrás
Lezárult
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
NCT04299464· 2. fázis· Forrás
Leállították
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD
NCT04632940· 3. fázis· Forrás
Lezárult
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
NCT04053842· 2. fázis· Forrás
Lezárult
Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.
NCT04644822· 3. fázis· Forrás
Lezárult
A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy
NCT04266795· 2. fázis· Forrás
Lezárult
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
NCT04670016· Forrás
Lezárult
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
NCT04303780· 3. fázis· Forrás
Lezárult
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT04182204· 3. fázis· Forrás
Lezárult
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
NCT04029480· 3. fázis· Forrás
Lezárult
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
NCT03832998· 3. fázis· Forrás
Lezárult
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
NCT03904693· 3. fázis· Forrás
Lezárult
Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
NCT03836417· Forrás
Lezárult
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
NCT03939689· 2. fázis· Forrás
Lezárult
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
NCT03594110· 3. fázis· Forrás
Lezárult
Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)
NCT03713593· 3. fázis· Forrás
Lezárult
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
NCT03455608· Forrás
Lezárult
PSMA-PET Registry for Recurrent Prostate Cancer
NCT03718260· Forrás
Lezárult
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
NCT03517449· 3. fázis· Forrás
Lezárult
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
NCT03511664· 3. fázis· Forrás
Leállították
A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT03452137· 3. fázis· Forrás
Lezárult
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
NCT03048825· 3. fázis· Forrás
Lezárult
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]
NCT03555422· 3. fázis· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
NCT03201965· 3. fázis· Forrás
Lezárult
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
NCT03173560· 2. fázis· Forrás
Lezárult
COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors
NCT03206021· 1. fázis· Forrás
Lezárult
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
NCT02975934· 3. fázis· Forrás
Lezárult
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
NCT03376438· Forrás
Lezárult
Undiagnosed COPD and Asthma Population Study (UCAP)
NCT03148210· Forrás
Lezárult
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
NCT03040999· 3. fázis· Forrás
Lezárult
CardiAMP™ Cell Therapy for Heart Failure Trial
NCT02438306· 3. fázis· Forrás
Lezárult
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
NCT02830360· 4. fázis· Forrás

Vizsgálati helyszínek

Intézményadatok: ROR 037tz0e16 (CC0-1.0)Frissítve: 2026. nov. 7.

Építés alatt, nem éles – London Health Sciences Centre: vizsgálatok és kutatócsoportok – Frontlight Research